Digital Disruption in Pharma
94.8K views | +0 today
Scooped by Pharma Guy
onto Digital Disruption in Pharma!

Can Purdue Pharma Ease the Pain of #Opioid Victims with Apple Watches for Chronic Pain "Therapy"?

Can Purdue Pharma Ease the Pain of #Opioid Victims with Apple Watches for Chronic Pain "Therapy"? | Digital Disruption in Pharma |

Purdue Pharma and Geisinger announced today that the first patient has been enrolled in the companies’ upcoming trial of medical wearables as an alternative therapy for chronic pain.

The ResearchKit study looks to see how wearables (in this case, the Apple Watch) can alleviate pain without relying on pharmaceutical painkillers, a commendable goal for a company whose painkilling opioid OxyContin has been at the heart of the US’ ongoing opioid epidemic.

“What we are really looking at is whether we can we decrease pain, improve functioning, and reduce reliance on pain medication,” Dr. Tracy Mayne, Purdue’s head of medical affairs strategic research, told MobiHealthNews in March. “They aren’t all necessarily ... taking opioids, but these are very sick patients with chronic pain and a lot of comorbidities, and I would be very surprised if even some of them haven’t been on pain medication for a long time.”

In the non-randomized prospective trial, 240 adult multidisciplinary pain-program patients receiving treatment within the Geisinger healthcare system will receive an Apple Watch to measure physical activity, self-reported pain, heart rate, medication use, and other relevant variables over 12 months. The watches will be outfitted with a specialized pain app and healthcare provider dashboard that not only integrates with Geisinger’s EMR, but suggests alternative pain treatment strategies such as stretching, mindfulness, and thermotherapy.

“The goal of this technology is to improve patient function and quality of life while reducing the need for analgesic medications. It provides objective measures of numerous aspects of pain, function, and treatment effectiveness so that information can be gathered for the patient and the healthcare provider in between visits,” Dr. Tracy Mayne, head of medical affairs strategic research for Purdue Pharma, said in a statement. “We are pleased to partner with Geisinger on this important initiative and believe real-time data may have the potential to support an improved understanding of chronic pain patients’ experiences and needs.”

Pharma Guy's insight:

I can't believe this crock of shite!

No comment yet.
Digital Disruption in Pharma
What's going on in the world of social media, mobile apps, mHealth, wearable & other digital technologies impacting the health industry
Curated by Pharma Guy